| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.05B | 14.31B | 12.90B | 12.16B | 11.68B | 12.98B |
| Gross Profit | 3.55B | 3.55B | 3.01B | 2.42B | 1.82B | 2.68B |
| EBITDA | 1.93B | 1.99B | 1.42B | 898.10M | 399.02M | 1.47B |
| Net Income | 845.70M | 823.06M | 583.22M | 231.88M | -1.29B | 1.41B |
Balance Sheet | ||||||
| Total Assets | 17.76B | 19.02B | 17.55B | 17.97B | 14.83B | 15.55B |
| Cash, Cash Equivalents and Short-Term Investments | 2.58B | 2.74B | 2.60B | 4.13B | 1.68B | 1.95B |
| Total Debt | 5.12B | 5.57B | 5.80B | 6.45B | 5.91B | 5.10B |
| Total Liabilities | 9.18B | 9.33B | 9.29B | 10.75B | 9.95B | 9.29B |
| Stockholders Equity | 7.69B | 8.69B | 7.36B | 6.44B | 4.13B | 5.61B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.47B | -288.37M | 184.41M | -945.58M | 553.91M |
| Operating Cash Flow | 0.00 | 2.26B | 415.03M | 1.02B | -129.29M | 1.88B |
| Investing Cash Flow | 0.00 | -802.56M | -619.22M | -782.15M | -806.76M | 601.29M |
| Financing Cash Flow | 0.00 | -1.40B | -1.45B | 2.13B | 550.98M | -2.05B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥15.61B | 15.61 | ― | 3.41% | -3.27% | 572.42% | |
74 Outperform | ¥60.34B | 24.26 | ― | 2.54% | 2.00% | 39.80% | |
69 Neutral | ¥72.33B | 10.78 | 7.00% | 3.02% | 15.78% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥27.87B | -53.89 | ― | 3.56% | -3.85% | -45.64% | |
61 Neutral | ¥280.84B | 8.88 | 7.67% | 0.91% | 9.03% | 10.76% | |
56 Neutral | ¥34.95B | 33.61 | ― | 0.45% | 13.61% | 94.37% |